Current Practice and Controversies in Screening for Gestational Diabetes

Gestational diabetes mellitus (GDM) is associated with fetal and maternal complications, and the prevalence has been increasing over the past decades. Hence, it is imperative to effectively screen, manage and monitor patients with GDM, but there continues to be a lack of consensus on optimal screeni...

Full description

Saved in:
Bibliographic Details
Published inCurrent diabetes reviews Vol. 19; no. 2; p. e130622205912
Main Authors Mallik, Ritwika, Huda, M S Bobby
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2023
Subjects
Consensus
COVID-19 - diagnosis
Diabetes, Gestational - diagnosis
Female
Humans
Mass Screening
Pandemics
Pregnancy
COVID-19
glucose intolerance
GDM
screening
Gestational diabetes
dyslipidaemia
Online AccessGet more information

Cover

More Information
Summary:Gestational diabetes mellitus (GDM) is associated with fetal and maternal complications, and the prevalence has been increasing over the past decades. Hence, it is imperative to effectively screen, manage and monitor patients with GDM, but there continues to be a lack of consensus on optimal screening for GDM internationally. In this review, we discuss the current screening methods for GDM, some of which are controversial and vary across several different healthcare systems. We also discuss the changes adapted to these guidelines during the COVID-19 pandemic and review novel approaches to the screening of GDM.
ISSN:1875-6417
DOI:10.2174/1573399819666220613154802